Morgan Stanley is a leading global financial services firm offering investment banking, wealth management, securities, and investment management services. With a strong global presence and deep market expertise, it serves corporations, governments, institutions, and individuals.
The firm is known for its strategic advisory capabilities, robust research, and role in shaping capital markets worldwide across asset classes. As per the latest corporate shareholdings filed, Morgan Stanley publicly holds 12 stocks with a net worth of over Rs. 1,029.8 crore.
Here are the stocks in which Morgan Stanley made a fresh investment in Q1FY26;
1. Cigniti Technologies
Cigniti Technologies Limited is primarily engaged in providing software testing services across the world. It offers services, including assurance, which includes test automation, security testing, and regression testing; engineering, which includes agile testing, performance engineering, and others.
With a market capitalization of Rs 4,343 Crores, the shares of Cigniti Technologies Limited closed at Rs. 1,585.25, up 0.71 percent from its previous day’s close price of Rs. 1,574.05.
Morgan Stanley, a well-known foreign institutional investor, has acquired 4,62,181 equity shares, representing a 1.7% stake in the company as of June 2025. This fresh investment reflects MS’s continued confidence in Indian equities. The company’s revenue stood at Rs 534 crore in Q1FY26. During the same time frame, net profit stood at Rs 66 crore.
2. Praveg
cis an India-based exhibition management company. The Company is a service company with a diversified portfolio, including exhibition management, event management, tourism and hospitality, and publication.
With a market capitalization of Rs 1,252 Crores, the shares of Praveg Limited closed at Rs. 479.20, down 2.12 percent from its previous day’s close price of Rs. 489.60.
Morgan Stanley, a well-known foreign institutional investor, has acquired 272,909 equity shares, representing a 1.0% stake in the company as of June 2025. This fresh investment reflects MS’s continued confidence in Indian equities. The company’s revenue stood at Rs 58.06 crore in Q4FY25. During the same time frame, net profit stood at Rs 3.33 crore.
3. Sirca Paints India
Sirca Paints India Limited is an India-based manufacturer of wood coating products. The Company is engaged in the manufacturing and sales of wood coatings and other decorative paints, under its own or exclusively licensed brands, such as Sirca, Unico, San Marco, and Durante Vivan.
With a market capitalization of Rs 2,285 crores, the shares of Sirca Paints India Limited closed at Rs. 416.90, down 0.84 percent from its previous day’s close price of Rs. 420.45.
Morgan Stanley, a prominent foreign institutional investor, made a fresh investment by acquiring 21,557 equity shares, amounting to a 0.04% stake in the company as of June 2025, signaling continued confidence in Indian equities. The company reported robust Q4FY25 financials, with revenue at Rs. 101 crore and net profit at Rs. 14 crore, reflecting strong operational performance and investor interest.
4. Niva Bupa Health Insurance Company Ltd
Niva Bupa Health Insurance Company Limited is the only health insurance company in India to be majority controlled by a foreign global healthcare group. Niva Bupa Health Insurance Company’s association with these foreign players gives it access to their international healthcare insurance experience.
With a market capitalization of Rs 15,487 Crores, the shares of Niva Bupa Health Insurance Company Limited closed at Rs. 83.94, down 3.13 percent from its previous day’s close price of Rs. 86.65.
Morgan Stanley has acquired 1% equity in the company by purchasing 1.85 crore shares in June 2025, signaling strong confidence in Indian equities. The company reported robust Q4FY25 financials, with revenue of Rs. 1,671 crore and a net profit of Rs. 206 crore, reflecting steady growth and strengthening investor interest in its long-term prospects.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
